SRL
AZN icon

Scientech Research LLC’s AstraZeneca AZN Stock Holding History

Scientech Research LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,028
Closed -$283K – 595
2025
Q2 		$283K Buy
+2,028
New +$284K 0.07% 463
2024
Q3 		– Sell
-2,612
Closed -$407K – 611
2024
Q2 		$407K Buy
+2,612
New +$393K 0.08% 376

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Scientech Research LLC's AZN Position: Q3 2025 in Review

Scientech Research LLC sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 2,028 shares — an estimated $283K sold.

Scientech Research LLC first reported a position in AZN in Q2 2024 and held it in 2 quarters. The position peaked at $407K in Q2 2024. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Scientech Research LLC reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
  • Scientech Research LLC sold 2,028 AstraZeneca shares in Q3 2025, an estimated $283K.
  • Scientech Research LLC first reported a position in AstraZeneca in Q2 2024 and held it in 2 quarters.
  • Scientech Research LLC's AstraZeneca position peaked at $407K in Q2 2024.
  • 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Scientech Research LLC's 13F filing for Q3 2025, filed 14 Nov 2025.